Sunil Agarwal MD Overview

  • Primary Position
  • Board Member

  • Active Board Seats
  • 2

Sunil Agarwal MD General Information

Biography

Dr. Sunil Agarwal serves as a Board Member at Arvinas. He serves as a Venture Partner at Forge Life Science Partners. He served as Board Member at Nēsos. He served as Executive Vice President, Head of Development, and Chief Medical Officer at Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines for patients, or Sana, since August 2018. He recently announced he will be departing from Sana in a planned transition after helping to onboard two senior leaders to its research and development organization. From April 2017 to August 2018, he served as President of Research and Development at Juno Therapeutics, a biopharmaceutical company. Previously, he was a Partner at Sofinnova, a biotech-focused investment firm. He also served as a former Executive Vice President and Chief Medical Officer at Ultragenyx Pharmaceutical, a biopharmaceutical company, where he managed the company's clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology, and toxicology functions. Additionally, he previously served in various leadership roles at Genentech, a biotechnology company, for more than a decade, including Senior Vice President and Global Head of Clinical Development for ophthalmology, metabolism, neurosciences, immunology, and infectious diseases. He led the approval of multiple therapies at Genentech including RITUXAN, ACTEMRA, LUCENTIS, and XOLAIR. Earlier in his career, he served at MedImmune and Guilford Pharmaceuticals, both pharmaceutical companies, where he served in both development and medical affairs and led the formation of Guilford's Medical Affairs Organization. He completed his residency at Children's National Medical Center (CNMC), Washington, D.C., and practiced in the CNMC Pediatric Emergency Department. He obtained his B.S. in neurobiology from Cornell University and earned his M.D. from Tufts University School of Medicine.

Contact Information

Primary Position
Board Member, Astria Therapeutics
Education
Cornell University, BS (Bachelor of Science)
Gender
Male
Phone
+1 (617)
Address
  • 75 State Street
  • Suite 1400
  • Boston, MA 02109
  • United States
+1 (617)

Sunil Agarwal MD Positions (1)

Firm name Firm type Title Location Industry Since
Forge Life Science Partners Investor Venture Partner MA Venture Capital

Sunil Agarwal MD Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Arvinas Drug Discovery Publicly Held Formerly VC-backed New Haven, CT
Astria Therapeutics Drug Discovery Publicly Held Formerly VC-backed Boston, MA
Calithera Biotechnology Out of Business Formerly VC-backed South San Francisco, CA

Sunil Agarwal MD Network (81)

Board Members (71)

Name Company Representing Location From
Andrew Levin Ph.D Arvinas RA Capital Management New Haven, CT
Wendy Yarno MyoKardia Self Brisbane, CA
Astria Therapeutics Self Boston, MA
MyoKardia Self Brisbane, CA
Astria Therapeutics MedImmune Ventures Boston, MA

Fund Team Members (10)

Name Investor Fund Fund Location
Anand Mehra MD Sofinnova Investments Sofinnova Venture Partners X Menlo Park, CA
Jason Pitts Ph.D Sofinnova Investments Sofinnova Venture Partners X Menlo Park, CA
Sofinnova Investments Menlo Park, CA
Sofinnova Investments Menlo Park, CA
Sofinnova Investments Menlo Park, CA

Sunil Agarwal MD Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Sofinnova Venture Partners X Sofinnova Investments Venture - General Closed 2016

Sunil Agarwal MD FAQs

  • Who is Sunil Agarwal MD?

    Dr. Sunil Agarwal serves as a Board Member at Arvinas.

  • How much does Sunil Agarwal MD typically invest?

    Sunil Agarwal MD's median deal size is .

  • What is Sunil Agarwal MD’s main position?

    Sunil Agarwal MD’s primary position is Board Member.

  • How many active board seats does Sunil Agarwal MD hold?

    Sunil Agarwal MD holds 3 board seats including Arvinas, Astria Therapeutics, and Calithera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »